Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | - | - | |
Diabetes Mellitus, Type 2 | Phase 2 | FR | - | |
Lipid Metabolism Disorders | Phase 2 | FR | - | |
Lipodystrophy | Phase 2 | - | - |